Orexigenic ghrelin secretion in HCV-infected patients with telaprevir- or simeprevir-based triple therapy

被引：0
|
作者：
Aoyama, Toru [1 ]
Nagoshi, Sumiko [1 ]
Yamamoto, Ryuichi [1 ]
Yamaguchi, Naomi [1 ]
Ohno, Shino [1 ]
Yakabi, Koji [1 ]
机构：
[1] Saitama Med Univ, Saitama Med Ctr, Dept Gastroenterol & Hepatol, Saitama, Japan
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1019
引用
收藏
页码：696A / 696A
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C
    Satoshi Yamagiwa
    Toru Ishikawa
    Nobuo Waguri
    Soichi Sugitani
    Hiroto Wakabayashi
    Shogo Ohkoshi
    Takashi Tsukishiro
    Toru Takahashi
    Toshiaki Watanabe
    Shuji Terai
    [J]. World Journal of Hepatology, 2017, (05) : 252 - 262
  • [2] Telaprevir-based and simeprevir-based interferon triple therapy for patients with hepatitis C
    Sasaki, Masato
    Tanaka, Hideki
    Takeguchi, Masataka
    Mochinaga, Takaho
    Matsushita, Hiroshi
    Kurano, Soutaro
    Nakamura, Aiko
    Yoshida, Kenichi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 382 - 382
  • [3] INHIBITORY EFFECTS OF TELAPREVIR ON OREXIGENIC GHRELIN SECRETION IN RATS AND PATIENTS WITH HCV INFECTION
    Aoyama, Toru
    Nagoshi, Sumiko
    Ochiai, Mitsuko
    Ro, Shoki
    Yamaguchi, Naomi
    Hosomi, Eriko
    Yamamoto, Ryuichi
    Yakabi, Koji
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S1014 - S1014
  • [4] FACTORS ASSOCIATED WITH FAILURE OF TELAPREVIR- AND BOCEPREVIR-BASED HCV TRIPLE THERAPY
    Bichoupan, K.
    Tandon, N.
    Martel-Laferriere, V
    Sachs, D.
    Ng, M.
    Schonfeld, E. A.
    Pappas, A.
    Crismale, J.
    Stivala, A.
    Khaitova, V
    Gardenier, D.
    Linderman, M.
    Olson, W.
    Perumalswami, P.
    Schiano, T. D.
    Odin, J. A.
    Liu, L. U.
    Dieterich, D. T.
    Branch, A. D.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A265 - A265
  • [5] Decrease of renal function in HCV and HIV/HCV-infected patients with telaprevir-based therapy
    Prinapori, Roberta
    Ricci, Elena
    Menzaghi, Barbara
    Borghi, Vanni
    Maggi, Paolo
    Martinelli, Canio
    Magni, Carlo
    Parruti, Giustino
    Bonfanti, Paolo
    Mussini, Cristina
    Di Biagio, Antonio
    [J]. AIDS, 2015, 29 (15) : 2061 - 2062
  • [6] TELAPREVIR- BASED THERAPY IN G1 HCV-INFECTED PATIENTS WITH PRIOR NULL RESPONSE, PARTIAL RESPONSE OR RELAPSE TO PEGINTERFERON/RIBAVIRIN: REALIZE TRIAL FINAL RESULTS
    Foster, G.
    Zeuzem, S.
    Andreone, P.
    Pol, S.
    Lawitz, E.
    Diago, M.
    Roberts, S.
    Focaccia, R.
    Younossi, Z.
    H, A.
    Heeswijk, R. V.
    de Meyer, S.
    Luo, D.
    Picchio, G.
    Beumont, M.
    [J]. GUT, 2011, 60 : A50 - A51
  • [7] Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV
    Tempestilli, Massimo
    Milano, Elisa
    D'Offizi, Gianpiero
    Montalbano, Marzia
    D'Avolio, Antonio
    Gasperi, Tecla
    Narciso, Pasquale
    Ascenzi, Paolo
    Pucillo, Leopoldo P.
    [J]. IUBMB LIFE, 2013, 65 (09) : 800 - 805
  • [8] Resistant-associated variants analyzed by deep sequence of retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infection
    Morishita, Naoki
    Hiramatsu, Naoki
    Oze, Tsugiko
    Tahata, Yuki
    Yamada, Ryoko
    Yakushijin, Takayuki
    Yamada, Akira
    Mita, Eiji
    Nagase, Toshihiko
    Yamada, Yukinori
    Ito, Toshifumi
    Tsujii, Masahiko
    Inada, Masami
    Imai, Yasuharu
    Hikita, Hayato
    Sakamori, Ryotaro
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Hayashi, Norio
    Takehara, Tetsuo
    [J]. HEPATOLOGY, 2015, 62 : 801A - 802A
  • [9] Adherence to therapy: Challenges in HCV-infected patients
    Pozza R.
    Barakat F.
    [J]. Current Hepatitis Reports, 2007, 6 (4) : 160 - 168
  • [10] Triple therapy with telaprevir (TPV) or boceprevir (BOC) in cirrhotic HIV/HCV-infected patients: real-life on-treatment data from Europe
    Miaihles, P.
    Lacombe, K.
    Arends, J. E.
    Puoti, M.
    Rosenthal, E.
    Morlat, P.
    Dominguez, S.
    Valantin, M. A.
    Gilbert, C.
    Winnock, M.
    Dabis, F.
    Rockstroh, J.
    Salmon, D.
    [J]. ANTIVIRAL THERAPY, 2013, 18 : A13 - A13
12345